The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

Experts fear a hyper virulent new strain of the virus, dubbed 'Nimbus', could drive a wave of cases this summer, with recent ...

A highly contagious Covid variant is on the rise in the UK, with official data suggesting rates have doubled in a month.

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

It scares me to think of what’s ahead,” said Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy. One of the members of the committee, who ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.. The new vaccine is indicated for active immunization to prevent COVID-19 caused ...

The Food and Drug Administration has approved Moderna's mNEXSPIKE (mRNA-1283), a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at ...

HHS Secretary Robert F. Kennedy Jr. says Moderna (MRNA) has agreed to do another clinical trial to back its newly approved next-gen COVID-19 vaccine. Read more here.

Get Instant Summarized Text (Gist) The FDA has approved Moderna's mNexspike, a lower-dose mRNA COVID-19 vaccine designed to elicit a focused immune response with about one-fifth the dose of Spikevax.

This fall, Moderna anticipates offering both Spikevax and mNexspike as COVID-19 vaccines. Their current vaccine, which is already available for individuals aged 6 months and older, does not ...